Corcept Therapeutics
CORT
CORT
209 hedge funds and large institutions have $1.94B invested in Corcept Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 89 reducing their positions, and 37 closing their positions.
Holders
209
Holders Change
-17
Holders Change %
-7.52%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.04%
New
22
Increased
62
Reduced
89
Closed
37
Calls
$12.5M
Puts
$9.73M
Net Calls
+$2.81M
Net Calls Change
+$1.81M
Top Buyers
| 1 |
1
BlackRock
New York
|
$385M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$295M |
| 3 |
BTW
3
Boston Trust Walden
Boston,
Massachusetts
|
$18.3M |
| 4 |
AWS
4
AJ Wealth Strategies
New York
|
$15.9M |
| 5 |
5
Allianz Asset Management
Munich,
Germany
|
$5.1M |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$209M |
| 2 |
ISL
2
Ingalls & Snyder LLC
New York
|
$165M |
| 3 |
3
LSV Asset Management
Chicago,
Illinois
|
$9.37M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$21.9M |
| 5 |
5
D.E. Shaw & Co
New York
|
$6.78M |
